InfuSystem (NYSE:INFU) Upgraded at StockNews.com

by · The Cerbat Gem

StockNews.com upgraded shares of InfuSystem (NYSE:INFU – Free Report) from a buy rating to a strong-buy rating in a report issued on Friday.

InfuSystem Trading Up 0.9 %

Shares of NYSE:INFU opened at $6.46 on Friday. The stock has a market cap of $137.57 million, a P/E ratio of -646,000.00 and a beta of 1.46. InfuSystem has a 12 month low of $5.74 and a 12 month high of $10.99. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.64 and a current ratio of 2.07.

InfuSystem (NYSE:INFU – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $33.70 million during the quarter. InfuSystem had a net margin of 0.28% and a return on equity of 0.70%.

Institutional Investors Weigh In On InfuSystem

Large investors have recently added to or reduced their stakes in the stock. Rhumbline Advisers lifted its position in shares of InfuSystem by 13.8% in the 2nd quarter. Rhumbline Advisers now owns 17,658 shares of the company’s stock worth $121,000 after purchasing an additional 2,145 shares during the period. Marshall Wace LLP purchased a new stake in shares of InfuSystem in the 2nd quarter worth approximately $131,000. Oppenheimer Asset Management Inc. lifted its position in shares of InfuSystem by 52.1% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the company’s stock worth $178,000 after purchasing an additional 8,917 shares during the period. Panagora Asset Management Inc. purchased a new stake in shares of InfuSystem in the 2nd quarter worth approximately $208,000. Finally, ARS Investment Partners LLC lifted its position in shares of InfuSystem by 11.4% in the 2nd quarter. ARS Investment Partners LLC now owns 33,510 shares of the company’s stock worth $229,000 after purchasing an additional 3,422 shares during the period. 71.13% of the stock is owned by hedge funds and other institutional investors.

About InfuSystem

(Get Free Report)

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Featured Stories